TickerGuard
Buy Day today: Neutral (47) Mixed market breadth · no major macro event
MNOV

MediciNova Inc

Healthcare · Biotechnology

1.60$ -2.4% vs. previous close Closing price · As of: Oct 7, 2026

Statements

Balance Sheet

MediciNova Inc (MNOV) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 40 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet MNOV
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
41 40 37 38 40 43 79 79 77 77 79 77 78 79 77 76 77 75 96 94 92 87 84 81 78 74 71 69 68 66 63 60 58 56 52 50 48 46 43 40
26 25 22 23 25 28 64 65 63 63 64 62 63 64 62 61 63 61 81 79 76 72 69 66 53 59 56 54 53 51 48 46 43 41 38 35 33 31 28 26
25 24 22 23 25 28 63 64 62 62 63 62 63 64 61 60 62 60 76 78 75 71 68 65 53 19 55 53 52 51 47 44 42 40 37 34 33 31 27 25
25 24 22 23 25 28 63 64 62 62 63 62 63 64 61 60 62 60 76 78 75 71 68 65 53 58 55 53 52 51 47 44 42 40 37 34 33 31 27 25
– – – – – – – – – – – – – – – – – – 4.0 – – – – – – – – – 1.0 – – – – – – 0.1 – – 0.2 –
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – – – – – – – – – 0.0 – – – – – – – – – 0.0 – – – – – – – – – – –
0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.9 0.1 0.1 0.1 0.0 0.0 0.0 0.1 – – – – – – – – – – – –
9.6 9.6 9.6 9.6 9.6 9.6 9.6 9.6 9.6 9.6 9.6 9.6 9.6 9.6 9.6 9.6 9.6 9.6 9.6 9.6 9.6 9.6 9.6 9.6 9.6 9.6 9.6 9.6 9.6 9.6 9.6 9.6 9.6 9.6 9.6 9.6 9.6 9.6 9.6 9.6
4.8 4.8 4.8 4.8 4.8 4.8 4.8 4.8 4.8 4.8 4.8 4.8 4.8 4.8 4.8 4.8 4.8 4.8 4.8 4.8 4.8 4.8 4.8 4.8 4.8 4.8 4.8 4.8 4.8 4.8 4.8 4.8 4.8 4.8 4.8 4.8 4.8 4.8 4.8 4.8
5.0 5.3 4.7 5.1 5.4 4.8 3.1 3.5 3.7 4.1 3.5 4.0 3.9 4.3 3.8 4.7 3.7 4.1 3.7 4.4 5.1 3.7 3.8 4.6 5.3 3.9 3.4 3.5 3.5 3.9 3.1 3.0 3.1 3.4 2.5 3.0 3.6 4.0 3.3 3.2
1.4 1.6 1.0 1.4 1.7 2.9 1.2 1.6 1.8 2.2 1.4 1.8 1.7 2.2 1.8 2.8 1.8 2.2 1.8 2.5 4.2 2.8 3.0 3.8 4.5 3.2 2.7 2.8 2.8 3.3 2.5 2.5 2.6 3.0 2.1 2.6 3.3 3.8 3.1 3.0
1,694 1,694 1,694 1,694 1,694 1,694 1,694 1,694 1,694 1,694 1,694 1,694 1,694 1,694 1,694 1,694 1,694 0.2 1,694 1,694 0.2 0.1 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.1
0.3 0.4 0.2 0.3 0.3 1.5 0.4 0.4 0.6 0.6 0.3 0.3 0.2 0.5 0.4 0.6 0.4 0.6 0.4 0.6 0.6 0.4 0.7 0.6 0.6 0.4 0.6 0.5 0.7 1.0 0.8 0.7 0.7 1.1 0.7 0.6 0.7 0.6 0.9 1.0
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – 0.2 0.3 – – – – – – – – – – – – – – – – – – – – – – – – – – – –
36 35 33 33 35 39 76 76 74 73 75 73 74 75 73 71 74 71 92 89 86 84 80 77 73 70 68 65 65 62 60 57 55 53 50 47 44 42 39 37
-329 -330 -333 -336 -340 -341 -346 -349 -356 -356 -361 -365 -367 -369 -372 -376 -380 -383 -383 -387 -391 -393 -396 -400 -404 -407 -410 -413 -414 -416 -418 -421 -424 -427 -430 -433 -436 -439 -441 -444
34 35 35 35 35 39 39 42 42 42 42 43 43 44 44 44 45 45 48 49 49 49 49 49 49 49 49 49 49 49 49 49 49 49 49 49 49 49 49 49

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?